Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2023-04-26 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a comprehensive credit limit (授信额度) and related board resolutions. It discusses the board meeting approval and the need for shareholder meeting authorization for credit facilities. There is no financial data, earnings, or detailed report content. The document is about financing activities and credit arrangements, which fits the Capital/Financing Update category. The document length is short and it is not a report publication announcement or certification. Therefore, the best classification is Capital/Financing Update (CAP).
2023-04-26 Chinese
康泰医学系统（秦皇岛）股份有限公司关于拟开展金融衍生品交易业务的可行性分析报告
Regulatory Filings Classification · 95% confidence The document is a detailed feasibility analysis report regarding the company's plan to engage in financial derivatives trading business. It includes purpose, business scope, risk analysis, risk control measures, and accounting principles. It is not an announcement of a report publication, nor a brief summary or regulatory filing. It contains substantive business and financial risk analysis content but does not present actual financial statements or quarterly/yearly financial results. It is not a management report or earnings release but a specific business feasibility report. Given the content and nature, it fits best under Regulatory Filings (RNS) as it is a regulatory disclosure about a new business activity and risk management, not a formal financial report or announcement of voting or capital changes.
2023-04-26 Chinese
《董事会议事规则》
Governance Information Classification · 95% confidence The document is titled "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of 康泰医学系统（秦皇岛）股份有限公司. The content details the responsibilities, organization, meeting procedures, duties, and powers of the board of directors, including sections on the chairman, board secretary, meeting convocations, proposals, voting, and execution of board resolutions. There is no financial data, audit information, or report content. Instead, it is a governance document outlining internal rules and governance practices of the board. This matches the description of Governance Information (CGR). The document length is substantial and it is not an announcement or a brief notice, so it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is CGR with high confidence.
2023-04-26 Chinese
2022年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the 2022年度财务决算报告 (2022 Annual Financial Settlement Report) of 康泰医学系统（秦皇岛）股份有限公司. It contains detailed audited financial statements, including balance sheets, income statements, cash flow statements, and financial ratios for the full fiscal year 2022. The audit opinion from Deloitte is included, confirming the financial statements are prepared according to accounting standards. The document is comprehensive, covering the entire fiscal year, with substantive financial data and analysis. It is not a short announcement or a certification letter but a full annual financial report. Therefore, it fits the definition of an Annual Report (10-K). FY 2022
2023-04-26 Chinese
关于拟开展金融衍生品交易业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 康泰医学系统（秦皇岛）股份有限公司 regarding its plan to engage in financial derivatives trading business. It details the types of derivatives, investment limits, risk analysis, and approvals by the board, supervisory committee, independent directors, and the sponsor institution. The document is a formal disclosure of a new business activity and its associated risks and governance, not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive information about the business decision and approvals. It is not a capital/financing update about fundraising or capital structure changes, but rather a regulatory announcement about a new financial activity. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-04-26 Chinese
关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of 康泰医学系统（秦皇岛）股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items including approval of the 2022 annual report, board and supervisory reports, financial statements, remuneration, and election of directors and supervisors. It also contains attachments such as the proxy form and shareholder registration form. The document is not the annual report itself but a formal notification and invitation to shareholders to attend and vote at the AGM. This fits the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM. The document length is over 6,700 characters, indicating it is a full notice rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2023-04-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.